After years of flying high, biopharma job growth is running into turbulence, a number of factors have increasingly pushed big pharma into layoffs. Although the picture is bleak now, the industry’s longer-term employment prospects appear brighter. Roche will eliminate 1,000 jobs by the end of 2013 when it shuts down its Nutley, NJ, R&D site. … Continue reading
The job losses at biotech firm Merck Serono were part of a wider restructuring plan “to create a leaner, more agile organisation,” the company said in a statement. “The planned measures for Merck Serono’s operations in Switzerland are needed to ensure our global competitive position in a rapidly changing market and to secure the long-term … Continue reading